News & insights

Medicines and medical devices regulation post-Brexit

by Matthew Royle, Ph.D.

Data exclusivity for innovators - a bridge too far?

by Andrew Payne

The EU-US Privacy Shield: getting your certification ready

by multiple authors

Reservation deposits and new build properties

The role of the Consumer Code for Homebuilders

by Lisa Bevan

First UK company to be liable for modern slavery

by Georgina Jones

Access to medicines in developing countries – what likely impact will GSK’s move have?

by Matthew Royle, Ph.D.

CJEU confirms orphan drug market exclusivity

by Matthew Royle, Ph.D.

Biosimilars and the issue of duplicates

by Dr Paul England and Matthew Royle, Ph.D.

Intellectual Property in the Life Sciences, in review

by Dr Paul England